Navigation Links
OrthoAccel Technologies, Inc. Selected to Pitch at the 2010 WBTshowcase
Date:3/16/2010

ARLINGTON, Texas, March 16 /PRNewswire/ -- OrthoAccel Technologies, Inc. is among the over 100 companies and technology innovators from across the nation and around the world that will compete for top honors at the WBT2010, March 16-17 in Arlington-DFW, Texas.

(Logo: http://www.newscom.com/cgi-bin/prnh/20091029/DA01250LOGO)

OrthoAccel's AcceleDent System, an acceleration device to enhance orthodontics, will be rigorously prepped by WBTshowcase commercialization experts to present to participants including venture capitalists and Fortune 1000 licensees. Over 500 professionals attended last year's event.

"The conventional wisdom for venture capital is that a down economy can be a great time to invest," said Paul Huleatt, WBTshowcase CEO. "The pace of new innovations accelerates, the best deals rise quickly to the top and sophisticated investors receive great value for their money."

According to Mr. Huleatt, one in three WBTshowcase presenters goes on to secure venture funding, license their technology, or sell their IP outright, representing over $450 million raised to date.

Michael Lowe, CEO of OrthoAccel, commented, "We are committed to building the AcceleDent brand around the customer above all else." Michael Kaufman, VP Business Development and Marketing for OrthoAccel remarked, "Introducing a new product category will come with many challenges; launching innovation always does. An exciting benefit of AcceleDent is that it can be used to enhance orthodontic treatment of any approach, regardless of the type of appliance or profile of patient."

Mr. Huleatt highlighted that the companies groomed to present at the WBTshowcase leave with new knowledge and contacts to take their technologies to the market and beyond.

OrthoAccel is nearing conclusion of another US clinical trial at the UT Health Science Center in San Antonio with an anticipated completion date during the first half of 2010.

About OrthoAccel Technologies, Inc.

Based in Houston, Texas, OrthoAccel Technologies, Inc. is a privately owned medical device company currently engaged in the development, manufacturing, and marketing of products to enhance dental care and orthodontic treatment.  

About the AcceleDent System

AcceleDent represents the first clinical approach to safely accelerate orthodontic tooth movement via modulating biology. The device has been studied clinically and applies gentle pulsing forces in combination with standard orthodontics to move teeth faster through accelerated bone remodeling. Importantly, the device works complementary with all existing orthodontic technologies. AcceleDent is neither FDA cleared nor FDA approved; it is currently investigational only in the United States.  More information can be found at www.acceledent.com or requested via info@orthoaccel.com

About WBTshowcase

The WBTshowcase is the nation's premier event showcasing the largest collection of undiscovered technologies emanating from the world's leading universities, labs and research institutions. The 2010 WBTshowcase will be held March 16-17 in Arlington-DFW, Texas. www.wbtshowcase.com

Media Contact Michael K. Lowe, CEO +1 (281) 798-5318

SOURCE OrthoAccel Technologies, Inc.

Back to top

RELATED LINKS
http://www.acceledent.com

'/>"/>

SOURCE OrthoAccel Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
2. Emisphere Technologies, Inc. Appoints Paul Lubetkin as Vice President and General Counsel
3. Microchip Biotechnologies, Inc. Secures Exclusive License to Use New University of Alberta Technology for Developing Microfluidic Devices
4. Emisphere Technologies, Inc. Appoints Michael R. Garone chief financial officer
5. Neurobiological Technologies, Inc. Reports Receipt of Notice From Nasdaq
6. Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2007 Results; Teleconference and Webcast to be held on September 18, 2007
7. Neurobiological Technologies, Inc. Reports Fourth Quarter and Fiscal Year-End Financial Results for 2007 Announces 1-for-7 Reverse Stock Split
8. Neurobiological Technologies, Inc. (Nasdaq: NTIID)
9. Emisphere Technologies, Inc. and Eli Lilly and Company Settle Ongoing Litigation
10. Maven Biotechnologies, LLC to Present at BIOCOM Investor Conference
11. Orchid Cellmark to Purchase ReliaGene Technologies, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... Singh ... orphan drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator of ... SBT-100 is able to cross the cell membrane and bind intracellular STAT3 and ...
(Date:10/10/2017)... International research firm Parks Associates announced today that ... TMA 2017 Annual Meeting , October 11 in Scottsdale, ... security market and how smart safety and security products impact the competitive ... Parks Associates: Smart Home Devices: Main ... "The residential security market has experienced continued ...
(Date:10/9/2017)... ... October 09, 2017 , ... The award-winning American Farmer television series will ... American Farmer airs Tuesdays at 8:30aET on RFD-TV. , With global population estimates ... of how to continue to feed a growing nation. At the same time, many ...
(Date:10/7/2017)... ... October 06, 2017 , ... ... Hi-C metagenome deconvolution product, featuring the first commercially available Hi-C kit. Researchers ... perform Hi-C metagenome deconvolution using their own facilities, supplementing the company’s full-service ...
Breaking Biology Technology:
(Date:4/17/2017)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... its 2016 Annual Report on Form 10-K on Thursday April 13, ... ... the Investor Relations section of the Company,s website at http://www.nxt-id.com ... http://www.sec.gov . 2016 Year Highlights: ...
(Date:4/11/2017)... , April 11, 2017 No two ... researchers at the New York University Tandon School ... Engineering have found that partial similarities between prints ... used in mobile phones and other electronic devices ... The vulnerability lies in the fact that ...
(Date:4/5/2017)... April 4, 2017 KEY FINDINGS ... expand at a CAGR of 25.76% during the forecast ... the primary factor for the growth of the stem ... https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global stem cell ... application, and geography. The stem cell market of the ...
Breaking Biology News(10 mins):